Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping

Akinci E., Yurdcu E., Orkun Ozbay B., Bodur H.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.24, sa.3, ss.96-98, 2018 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4274/vhd.2018.0022
  • Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.96-98
  • Anahtar Kelimeler: Chronic hepatitis C, direct-acting antivirals, hepatitis C virus, RESISTANCE
  • Ankara Üniversitesi Adresli: Evet

Özet

Current direct acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in the treatment failure and relapse. In this paper, we present two cases of hepatitis C in which DAAs failed due to incomplete HCV genotyping.